Creation of insulin was a revolutionary event in the world of diabetes, but the first insulins were poorly treated, and therefore imperfect. Moreover, animal insulin had increased immunogenicity, resulting in complications of various types. Best insulin today - human, produced by genetic engineering, but he has flaws - the need to introduce for thirty minutes before meals and duration of up to twelve hours, which increases the risk of later development of hypoglycemia. Therefore, scientists around the world have continued to work to improve insulin and have new tools, called insulin analogues.
Insulin analogues
In the early eighties of the twentieth century began to strengthen the work on optimization of insulin that would be better than a human. As a result, changing the amino acid sequence in the molecule of insulin preparations have been produced which are called insulin analogues - they are as close as possible to the physiological action of insulin.
Insulin analogues just starting to act very early, almost immediately after the introduction and prevent re-lifting glucose
Glucose: The energy source
a few hours after injection.
Prolonged insulin analogs designed to simulate the basic insulin secretion, thus providing physiological approach to insulin
The basic principles of insulin - is correct in everything
Helping to achieve a controlled hyperglycemia and minimize the risk of hypoglycemia. Currently known insulin analogues not only ultrashort and long-acting, but also mixtures thereof in a fixed ratio.
Analogs of regular insulin
Very important is the fact that short-acting insulin analogues, which include Humalog, Apidra and NovoRapid Penfill provide rapid development of peak concentrations and rapid elimination, which corresponds better to the physiological insulin secretion peak.
It is known that the introduction of a simple short-acting insulin (human obtained by genetic engineering), the duration of its action is directly proportional to the dose, and is in the range of six to twelve hours, which is not convenient for preventing hypoglycemia later. Short-acting insulin analogues have a maximum term of five hours, which reduces the risk of hypoglycemia later.
Prolonged insulin analogues
Prolonged insulin analogs, which include Penfill Levemir and Lantus, mimic the basic insulin secretion. Lantus - insulin analogue ultralong action, it is sufficient administered once a day after the injection because it provides a slow flow of hormones in the blood, which further contributes to the addition of a small amount of zinc preparation.
Lantus takes effect within one hour after administration, reaching steady state concentrations after two - four days, which is not related to the time and place of administration. Analogs of the prolonged insulin (Lantus) are similar in effect to the physiological insulin
The principles of action of insulin - the science of saving lives
: Stimulate insulin-dependent glucose uptake by tissues, inhibit gluconeogenesis, thereby reducing the level of glucose in the blood, as well as inhibit lipolysis and proteolysis, i.e., increase protein synthesis.
Combined insulin analogues
By the combination of insulin analogues are Penfill and Humalog miks25 that are used mainly in elderly patients suffering from age-diabetes
Diabetes - threatening and incurable disease
, Which are characterized by forgetfulness. Therefore, it is important to have available a drug that controls the level of glucose in the blood, allowing the introduction of the food, during it or immediately after. The combined action of insulin analogues to help patients achieve such a satisfactory compensation for a small number of complications.
Svetlana Shimkovich